Olema Pharmaceuticals (OLMA) Times Interest Earned (2020 - 2026)
Olema Pharmaceuticals' (OLMA) quarterly Times Interest Earned came in at -$0.63 in Q1 2026, up 97.61% year-on-year from -$0.32 in Q1 2025, and up 99.57% on a QoQ basis from -$147.04 in Q3 2025.
Olema Pharmaceuticals (OLMA) Times Interest Earned (2020 - 2026) Analysis & Trends
Olema Pharmaceuticals (OLMA) has 7 years of Times Interest Earned data on file, last reported at -$0.63 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 97.61% year-over-year to -$0.63 in Q1 2026; TTM through Mar 2026 was -$2.2, a 97.97% increase from a year earlier, with the FY2025 full-year figure at -$0.76, up 95.99% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$0.63, up from -$147.04 in the prior quarter.
- Over the last five years, Times Interest Earned for OLMA reached as high as -$0.43 in Q3 2023 and fell as low as -$147.04 in Q3 2025.
- Historically, Times Interest Earned has averaged -$35.04 across 5 years, with a median of -$8.36 in 2022.
- Across the five-year window, Times Interest Earned tumbled 17189.25% in 2025 and soared 97.61% in 2026, its largest moves.
- Year by year, Times Interest Earned stood at -$84.27 in 2022, then sank by 37.24% to -$115.65 in 2023, then dropped by 3.9% to -$120.16 in 2024, then decreased by 22.37% to -$147.04 in 2025, then jumped by 99.57% to -$0.63 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$0.63 in Q1 2026, -$147.04 in Q3 2025, and -$24.77 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Olema Pharmaceuticals | 1.21 Bn | 1.21 Bn | - | -0.63 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.63 |
| Sep 30, 2025 | -147.04 |
| Jun 30, 2025 | -24.77 |
| Mar 31, 2025 | -26.42 |
| Dec 31, 2024 | -120.16 |
| Sep 30, 2024 | -0.85 |
| Jun 30, 2024 | -0.90 |
| Mar 31, 2024 | -0.84 |
| Dec 31, 2023 | -115.65 |
| Sep 30, 2023 | -0.43 |
| Jun 30, 2023 | -0.68 |
| Mar 31, 2023 | -14.59 |
| Dec 31, 2022 | -84.27 |
| Sep 30, 2022 | -7.26 |
| Jun 30, 2022 | -9.47 |
| Mar 31, 2022 | -6.62 |
| Dec 31, 2021 | -1.03 |
| Sep 30, 2021 | -0.25 |
| Jun 30, 2021 | -0.20 |
| Mar 31, 2021 | -0.14 |